4D Molecular Therapeutics FDMT
NASDAQ FDMT
$12.99 +0.53 (+4.25%)
At close: Nov 11, 2026 · 4:00 PM EST

4D Molecular Therapeutics (FDMT) Construction in Progress (2020 - 2026)

Updated

Analysis

4D Molecular Therapeutics (FDMT) Construction in Progress (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 4D Molecular Therapeutics 875.59 Mn -584.35 Mn - 49,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49,000.00
Sep 30, 2025 50,000.00
Jun 30, 2025 128,000.00
Mar 31, 2025 1.05 Mn
Dec 31, 2024 1.18 Mn
Sep 30, 2024 2.02 Mn
Jun 30, 2024 299,000.00
Dec 31, 2023 550,000.00
Sep 30, 2023 1.03 Mn
Jun 30, 2023 804,000.00
Mar 31, 2023 520,000.00
Dec 31, 2022 476,000.00
Sep 30, 2022 1.01 Mn
Jun 30, 2022 815,000.00
Mar 31, 2022 13.20 Mn
Dec 31, 2021 10.07 Mn
Sep 30, 2021 4.33 Mn
Dec 31, 2020 539,000.00
API Access

4D Molecular Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=FDMT&period=max&api_key=YOUR_API_KEY